The global surgical robots market is experiencing significant growth, driven by technological advancements, increasing demand for minimally invasive procedures, and the rising prevalence of chronic diseases. As healthcare providers seek innovative solutions to enhance surgical outcomes, the adoption of robotic-assisted surgeries is on the rise.
The global surgical robots market size was valued at USD 1,463.0 million in 2018 and is projected to reach USD 22,381.6 million by 2032, registering a robust CAGR of 21.5% during the forecast period (2018–2032). In 2018, North America led the global market, accounting for a dominant share of 71.46%.
Leading players contributing to innovation and expansion in the surgical robots industry include:
In May 2018, Intuitive Surgical Inc. received FDA clearance in the United States for the da Vinci X Surgical System. This system offers urologic surgical procedures through a single port approach, enhancing precision and reducing recovery times.